论文部分内容阅读
目的 :研究糖皮质激素对肿瘤内科患者治疗的干预效果。方法 :选择2014年3月-2016年3月,到医院就诊的肿瘤内科患者122例,随机分为对照组和观察组,每组患者61例。对照组患者仅采用常规方法进行治疗,观察组患者在常规治疗的基础上,加用糖皮质激素进行治疗。治疗后,对比两组患者的治疗效果,以及发生不良反应的几率。结果 :治疗后,观察组患者的治疗总有效率为90.16%,高于对照组患者的65.57%(P<0.05)。治疗后,观察组患者发生不良反应的几率为11.48%,低于对照组患者的37.70%(P<0.05)。结论 :在肿瘤内科患者的治疗中,使用糖皮质激素进行辅助治疗,能够取得更好的干预效果。
Objective: To study the intervention effect of glucocorticoid on the treatment of cancer patients. Methods: From March 2014 to March 2016, 122 patients with medical oncology admitted to the hospital were randomly divided into control group and observation group, with 61 patients in each group. Patients in the control group were treated by conventional methods only. Patients in the observation group were treated with glucocorticoid on the basis of conventional treatment. After treatment, the two groups of patients were compared with the treatment effect, as well as the probability of adverse reactions. Results: After treatment, the total effective rate of the observation group was 90.16%, which was higher than that of the control group (65.57%, P <0.05). After treatment, the incidence of adverse reactions in the observation group was 11.48%, which was lower than that in the control group (37.70%, P <0.05). Conclusion: In the treatment of patients with medical oncology, the use of glucocorticoid adjuvant therapy can achieve better intervention effect.